Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Tosoh Bioscience HLC-723G8 Analyzer for HbA1c testing. Recalled by Tosoh Bioscience, Inc. Due to The device defect associated with this recall may...

Date: November 7, 2016
Company: Tosoh Bioscience, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Tosoh Bioscience, Inc. directly.

Affected Products

Tosoh Bioscience HLC-723G8 Analyzer for HbA1c testing.

Quantity: 682 analyzers

Why Was This Recalled?

The device defect associated with this recall may result in HbA1c values with a negative bias in patients with the hemoglobin variants C, D, E and S. The negative bias occurs at the higher levels of HbA1c, e.g. 9%, but not at the diagnostic medical decision point of 6.5%.

Where Was This Sold?

This product was distributed to 48 states: AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY

Affected (48 states)Not affected

About Tosoh Bioscience, Inc.

Tosoh Bioscience, Inc. has 5 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report